首页> 外国专利> The curative medicine of the fusion protein, and the Hirotune Characteristic heaven smallpox which are recognized in the Hirotune Characteristic heaven smallpox patient self antibody, being the remedy instrument, and the fusion

The curative medicine of the fusion protein, and the Hirotune Characteristic heaven smallpox which are recognized in the Hirotune Characteristic heaven smallpox patient self antibody, being the remedy instrument, and the fusion

机译:广谱特征天堂天花患者自身抗体中识别的融合蛋白的治疗药物和广谱特征天花,作为治疗手段,以及融合

摘要

PURPOSE: To obtain a fused protein capable of being recognized with an autoantibody of a pemphigus vulgaris patient by ligating the hinge part of the constant region of IgG to the C-terminal of the extracellular region of a pemphigus vulgaris antigen protein. CONSTITUTION: A fused protein is produced by ligating the hinge part of the constant region of IgG to the C-terminal of a protein which is represented by the sequence of the formula and which is the extracellular region (PVAg) of a pemphigus vulgaris antigen protein. When a gene coding the fused protein is transduced into an animal cell or an insect cell to express the fused protein, the expressed fused protein can accurately be discharged from the cell, because of using the amino acid sequence of the PVAg. Since the hinge part of the constant region of the IgG is ligated, the fused protein can stably be produced, and the high-dimensional structure of the PVAg is the same as that of the natural PVAg. Since the IgG is ligated to the cut part of the C-terminal side, the autoantibody can surely be recognized. Further, since the IgG is contained, the presence or absence of the expressron after transduced in the cell can easily be examined, and the purification of the fused protein after the expression is facilitated.
机译:目的:通过将IgG恒定区的铰链部分连接到寻常型天疱疮抗原蛋白的细胞外区域的C末端,获得能够被寻常型天疱疮患者的自身抗体识别的融合蛋白。组成:融合蛋白是通过将IgG恒定区的铰链部分连接至该蛋白的C端而产生的,该蛋白由分子式的序列表示,并且是寻常型天疱疮抗原蛋白的胞外区(PVAg) 。当将编码融合蛋白的基因转导到动物细胞或昆虫细胞中以表达融合蛋白时,由于使用了PVAg的氨基酸序列,因此可以将表达的融合蛋白准确地从细胞中排出。由于连接了IgG恒定区的铰链部分,因此可以稳定地产生融合蛋白,并且PVAg的高维结构与天然PVAg的高维结构相同。由于IgG与C末端侧的切口部分连接,因此可以可靠地识别自身抗体。此外,由于包含IgG,因此可以容易地检查在细胞中转导后表达子的存在与否,并且促进表达后的融合蛋白的纯化。

著录项

  • 公开/公告号JP4297519B2

    专利类型

  • 公开/公告日2009-07-15

    原文格式PDF

  • 申请/专利权人 西川 武二;

    申请/专利号JP19950165632

  • 申请日1995-06-30

  • 分类号C07K19/00;A61K39/00;A61K39/385;A61K49/00;A61P37/06;A61P17/00;G01N33/564;A61M1/36;C12N15/09;C07K14/47;C07K16/28;C12P21/02;C12R1/91;

  • 国家 JP

  • 入库时间 2022-08-21 19:41:15

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号